Albert Maguire
University of Pennsylvania
2026 Breakthrough Prize in Life Sciences
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.
Laureates
University of Pennsylvania
For developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease.